Market Cap (In KRW)
517.73 Billion
Revenue (In KRW)
748.52 Billion
Net Income (In KRW)
37 Billion
Avg. Volume
14.00
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 53200.0-62800.0
- PE
- -
- EPS
- -
- Beta Value
- 0.506
- ISIN
- KR7001062009
- CUSIP
- -
- CIK
- -
- Shares
- 7864982.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Young-Sub Shin
- Employee Count
- -
- Website
- https://www.jw-pharma.co.kr
- Ipo Date
- 2005-09-29
- Details
- JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
More Stocks
-
SVE
-
CMRE-PDCostamare Inc.
CMRE-PD
-
084680E-World Co.,Ltd.
084680
-
VCU
-
ACAZFAcadian Timber Corp.
ACAZF
-
002990Maxvision Technology Corp.
002990
-
IND
-
MEAPL